Organoid Science announced on the 2nd that it will attend the 2022 American Society of Clinical Oncology (ASCO) held in Chicago, USA from June 3rd to 7th (local time).
ASCO, one of the world’s top three cancer societies, is an annual event attended by medical officials, scientists, multinational pharmaceutical companies and bio companies to present the latest research results and anticancer drug clinical data.
The efficacy evaluation platform developed by Organoid Science is capable of evaluating all types of anticancer drugs that directly kill cancer cells, such as chemical anticancer drugs, targeted anticancer drugs, immune checkpoint inhibitors, immunotherapies such as CAR-T/NK, and radiotherapy. It is a patient-derived organoid-based screening technology that can dramatically reduce the time and cost required for clinical trials.
Organoid Science will operate a separate offline booth during the event to inform local researchers and partners of the excellence of the organoid-based efficacy evaluation platform that can be applied to various fields, including the anticancer field, as well as the imaging-based technology that received great response at the last AACR. The organoid dispenser automation device is demonstrated.
What is noteworthy is that new solutions being developed for researchers conducting research and development using organoids and medical institutions such as hospitals will be unveiled for the first time at this conference. If you visit the booth (#28086), we plan to provide more detailed information and introduce it to conference participants.
Jongman Yoo, CEO of Organoid Science, said, “As the high utility of organoids for various cancer types is increasingly emerging, ASCO, a world-renowned academic society, focused on the value of organoids rather than simply dealing with data,” and added, “We will continue to conduct research and development. “This will be the most important momentum to leap forward as a global hub company that deals with everything related to organoids,” he added.
Source: Pangyo Techno Valley Official Newsroom
→ Go to ‘Asia Innovation Hub Pangyo Techno Valley 2022’ news